1. Home
  2. SLS vs SOTK Comparison

SLS vs SOTK Comparison

Compare SLS & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • SOTK
  • Stock Information
  • Founded
  • SLS 2012
  • SOTK 1975
  • Country
  • SLS United States
  • SOTK United States
  • Employees
  • SLS N/A
  • SOTK N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • SOTK Industrial Machinery/Components
  • Sector
  • SLS Health Care
  • SOTK Technology
  • Exchange
  • SLS Nasdaq
  • SOTK Nasdaq
  • Market Cap
  • SLS 238.7M
  • SOTK 52.1M
  • IPO Year
  • SLS N/A
  • SOTK 1987
  • Fundamental
  • Price
  • SLS $1.66
  • SOTK $4.61
  • Analyst Decision
  • SLS Strong Buy
  • SOTK Hold
  • Analyst Count
  • SLS 1
  • SOTK 1
  • Target Price
  • SLS $7.00
  • SOTK N/A
  • AVG Volume (30 Days)
  • SLS 5.2M
  • SOTK 50.4K
  • Earning Date
  • SLS 11-07-2025
  • SOTK 10-14-2025
  • Dividend Yield
  • SLS N/A
  • SOTK N/A
  • EPS Growth
  • SLS N/A
  • SOTK 6.63
  • EPS
  • SLS N/A
  • SOTK 0.10
  • Revenue
  • SLS N/A
  • SOTK $20,607,030.00
  • Revenue This Year
  • SLS N/A
  • SOTK $2.67
  • Revenue Next Year
  • SLS N/A
  • SOTK $8.20
  • P/E Ratio
  • SLS N/A
  • SOTK $47.93
  • Revenue Growth
  • SLS N/A
  • SOTK N/A
  • 52 Week Low
  • SLS $0.77
  • SOTK $3.23
  • 52 Week High
  • SLS $2.48
  • SOTK $6.05
  • Technical
  • Relative Strength Index (RSI)
  • SLS 38.10
  • SOTK 59.63
  • Support Level
  • SLS $1.85
  • SOTK $4.36
  • Resistance Level
  • SLS $2.06
  • SOTK $4.96
  • Average True Range (ATR)
  • SLS 0.17
  • SOTK 0.39
  • MACD
  • SLS -0.04
  • SOTK -0.01
  • Stochastic Oscillator
  • SLS 1.20
  • SOTK 47.57

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

Share on Social Networks: